* Note: Prices are in Million (M) USD.
Description:
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $183 M
Debt : $1,951 M
EBITDA : $379 M
Net Debt (Debt - Cash): $1,768 M
Since EBITDA cannot cover net debt within 3 years, Avoid This Stock.
This criteria used industry in which company operates:
Sector: Health Care
Industry: Medical Care Facilities
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 16.04
Since Forward PE Ratio is between 15 - 20, 3 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $212 M
Average Revenue: $1,799 M
Revenue Converted To Free Cash Flow (%): 12%
Avg Free Cash Flow Growth Per Year (Last 3 Years): -2.20%
Since Free Cash Flow (FCF) to Revenue percentage is less than 15, 1 point assigned.
This criteria used company's growth potential to calculate its fair value:
Error: This stock does not have 5 years of revenue data.Using default values for calculation.
Based on default values, 1 points assigned.
This criteria used Company's ability to buy back its own share:
Error: This stock does not have 5 years of share count data.Using default values for calculation.
Based on default values, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $1.54
Trailing 12-Month Earnings Per Share (EPS): $1.31
Average Earnings Per Share (EPS): $1.43
Dividend Per Share (DPS): $0
Payout Ratio: 9%
Dividend Yield: 1%
Since company Payout Ratio is less than 50, 2 points assigned.
Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: 31%
Since Average ROE is greater than 20, 5 points assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $23
52-Week Low: $19
Threshold Price (15% Above 52-Week Low): $22
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $2,520 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 2% exposure of Total Portfolio.
Value-Trade has assigned 15 points to above Concentra Group Holdings Parent, Inc. (CON) stock.
Last 1 Years Avg PE (Limited to last 1 years of EPS data) 19.01, Fair Value PE 12 and Industry Based PE is 15. Based on these three values average assigned is 15.34.
Value-Trades has assined P/E value 15.34. Since an average (Current Year EPS + Next Year EPS) earning per share is $1.425.
The fair value of Concentra Group Holdings Parent, Inc. (CON) stock should be (15.34 x $1.425) = $21.86
